Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
- 13 July 1990
- journal article
- Published by Elsevier BV in Cell
- Vol. 62 (1), 175-185
- https://doi.org/10.1016/0092-8674(90)90251-9
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large TCell, 1990
- Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.The Journal of cell biology, 1989
- Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationCell, 1989
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcomaNature, 1989
- Transforming growth factor (TGF?) decreases the proliferation of human bone marrow fibroblasts by inhibiting the platelet-derived growth factor (PDGF) bindingExperimental Cell Research, 1988
- TGF‐β inhibits growth factor‐induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic eventsJournal of Cellular Physiology, 1988
- Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor β in a human breast carcinoma cell lineBiochemical and Biophysical Research Communications, 1987
- The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptorsCell, 1987